EcoDrugPlus

Melanocortin 1 Receptor

Ensembl ID : ENSSMAG00000001276
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSSMAG00000008050
Gene Symbol: MC4R
3 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSSMAG00000001284
Gene Symbol: MTNR1AA
3 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSSMAG00000011821
Gene Symbol: MME
3 Cross references
231 Possible Orthologues:

Metabotropic Glutamate Receptor 4-Like

Ensembl ID : ENSSMAG00000008192
Gene Symbol: LOC118308845
2 Cross references
207 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSSMAG00000005667
Gene Symbol: METAP2
1 Cross references
220 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSSMAG00000006620
Gene Symbol: MAPK10
3 Cross references
88 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSSMAG00000012001
Gene Symbol: MAPK11
2 Cross references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 14b

Ensembl ID : ENSSMAG00000006989
Gene Symbol: MAPK14B
2 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSSMAG00000009704
Gene Symbol: MAPK3
3 Cross references
197 Possible Orthologues:

Mitogen-Activated Protein Kinase 8a

Ensembl ID : ENSSMAG00000004251
Gene Symbol: MAPK8A
3 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase 8b

Ensembl ID : ENSSMAG00000005641
Gene Symbol: MAPK8B
1 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).